Evaluating the hepatitis B vaccination impact in the Republic of Moldova: A nationwide representative serosurvey of children born in 2013
Hepatitis B
Seroprevalence
DOI:
10.1016/j.ijregi.2023.11.003
Publication Date:
2023-11-08T12:59:25Z
AUTHORS (14)
ABSTRACT
The WHO European Region set targets for the control of hepatitis B through immunization, including prevalence surface antigen (HBsAg) at ≤0.5% in vaccinated cohorts. Republic Moldova implemented universal vaccination since 1995. We conducted a nationwide representative serosurvey to estimate HBsAg seroprevalence children born 2013 validate targets.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....